Morphoceuticals
Jim Jenson is the CEO and Director at Morphoceuticals, Inc. Jim is also a Strategic Adviser and Founding CEO at CytoSite Biopharma Inc. Additionally, Jim is a Founding Member of the BioPharma Executive Council and The BioPharma Hub. Jim has experience as the Founding CEO at Sabik Medical Inc., Dicerna Pharmaceuticals, Inc., Zapaq, Inc./CoMentis, Inc., Polaris Pharmaceuticals, and as the VP Research at Procept. Jim has also served as the Director Protein Chemistry and Chairman SAB at Triton Biosciences/Berlex Biosciences/Schering AG and as a Research Investigator and Head of the Molecular Immunology Group at Hoffmann-LaRoche. Jim holds a BA in Biology from Macalester College and a PhD in Biology/Biochemistry from Cornell University.
This person is not in any teams